Premium
Coronary access after valve‐in‐valve transcatheter aortic valve replacement: Time for a prospective study?
Author(s) -
Tang Gilbert H. L.,
Dangas George D.
Publication year - 2021
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.29879
Subject(s) - medicine , cardiology , heart valve , valve replacement , hemodynamics , coronary artery disease , aortic valve , implant , artery , surgery , stenosis
Key Points Although the durability of heart valves in younger patients remains unknown, those with coronary artery disease will likely progress and require intervention. The ACURATE‐neo valve has the lowest frame profile among the various devices currently in use or under clinical investigation. A deeper implant in valve‐in‐valve transcatheter implantation did not appear to impact its hemodynamic performance but rather facilitates coronary access. Future prospective studies should evaluate the concept of transcatheter valve frame‐to‐coronary distance in various transcatheter heart valves devices.